Elequin Capital’s Bruker BRKR Stock Holding History

Elequin Capital’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-231	Closed	-$10.9K	–	633
2025 Q4	$10.9K	Buy	+231	New	+$9.76K	﹤0.01%	233

Other funds holding BRKR

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Elequin Capital's BRKR Position: Q1 2026 in Review

Elequin Capital sold out of Bruker (BRKR) in Q1 2026, closing a stake of 231 shares — an estimated $10.9K sold.

Elequin Capital first reported a position in BRKR in Q4 2025 and held it in 1 quarter. The position peaked at $10.9K in Q4 2025. 345 funds tracked by Wall St. Rank hold BRKR as of Q1 2026.

Elequin Capital reported no remaining Bruker position as of Q1 2026 after selling out during the quarter.
Elequin Capital sold 231 Bruker shares in Q1 2026, an estimated $10.9K.
Elequin Capital first reported a position in Bruker in Q4 2025 and held it in 1 quarter.
Elequin Capital's Bruker position peaked at $10.9K in Q4 2025.
345 funds tracked by Wall St. Rank held Bruker as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.